| 2019 | Indoor radon exposure increases tumor mutation burden in never-smoker patients with lung adenocarcinoma | 김혜련, 박성용, 심효섭, 이창영, 조병철, 홍민희 | Article |
| 2019 | The Ratio of Peripheral Regulatory T Cells to Lox-1+ Polymorphonuclear Myeloid-derived Suppressor Cells Predicts the Early Response to Anti-PD-1 Therapy in Patients with Non-Small Cell Lung Cancer | 김혜련, 윤홍인, 정인경, 조병철 | Article |
| 2019 | A phase Ib study of the combination of afatinib and ruxolitinib in EGFR mutant NSCLC with progression on EGFR-TKIs | 김혜련, 조병철, 홍민희 | Article |
| 2019 | Investigating the Feasibility of Targeted Next-Generation Sequencing to Guide the Treatment of Head and Neck Squamous Cell Carcinoma
| 김상우, 김혜련, 조병철 | Article |
| 2019 | A Randomized, Open-Label, Phase II Study Comparing Pemetrexed Plus Cisplatin Followed by Maintenance Pemetrexed versus Pemetrexed Alone in Patients with Epidermal Growth Factor Receptor (EGFR)-Mutant Non-small Cell Lung Cancer after Failure of First-Line EGFR Tyrosine Kinase Inhibitor: KCSG-LU12-13
| 김혜련 | Article |
| 2019 | Comprehensive analysis of the characteristics and treatment outcomes of patients with non-small cell lung cancer treated with anti-PD-1 therapy in real-world practice
| 김혜련, 박성용, 심효섭, 안병철, 윤홍인, 이창영, 조병철, 표경호, 홍민희 | Article |
| 2019 | YH25448, an Irreversible EGFR-TKI with Potent Intracranial Activity in EGFR Mutant Non-Small Cell Lung Cancer | 김혜련, 조병철, 표경호, 홍민희 | Article |
| 2019 | TRIUMPH Trial: One Small Step Could Become One Giant Leap for Precision Oncology in Head and Neck Cancer
| 김혜련 | Article |
| 2019 | Real-World Analysis of the Efficacy of Rebiopsy and EGFR Mutation Test of Tissue and Plasma Samples in Drug-Resistant Non-Small Cell Lung Cancer
| 김지형, 김혜련, 안병철, 조병철, 허수진, 홍민희 | Article |
| 2019 | Neoadjuvant therapy for thymic neoplasms reduces tumor volume per 3D-reconstructed images but does not improve the complete resection rate | 김대준, 김혜련, 박성용, 백효채, 서지원, 송승환, 이진구, 이창영, 정경영, 조병철, 홍민희 | Article |
| 2018 | Brigatinib versus Crizotinib in ALK-Positive Non–Small-Cell Lung Cancer | 김혜련 | Article |
| 2018 | ERK-dependent IL-6 autocrine signaling mediates adaptive resistance to pan-PI3K inhibitor BKM120 in head and neck squamous cell carcinoma | 강한나, 김혜련, 윤미란, 조병철, 홍민희 | Article |
| 2018 | Radon Exposure-induced Genetic Variations in Lung Cancers among Never Smokers
| 김혜련 | Article |
| 2018 | Survival and Functional Outcome after Treatment for Primary Base of Tongue Cancer: A Comparison of Definitive Chemoradiotherapy versus Surgery Followed by Adjuvant Radiotherapy.
| 고윤우, 금기창, 김세헌, 김혜련, 이정심, 이창걸, 조연아, 최은창 | Article |
| 2018 | Characteristics and Outcome of ROS1-Positive Non-Small Cell Lung Cancer Patients in Routine Clinical Practice | 김혜련, 안병철, 조병철, 홍민희 | Article |
| 2018 | Efficacy and safety of vinorelbine plus cisplatin chemotherapy for patients with recurrent and/or metastatic salivary gland cancer of the head and neck | 고윤우, 김진아, 김혜련, 윤선옥, 조병철, 최은창, 홍민희 | Article |
| 2018 | Establishment of a platform of non-small-cell lung cancer patient-derived xenografts with clinical and genomic annotation | 김대준, 김진아, 김혜련, 박성용, 백순명, 심효섭, 윤미란, 이진구, 이한나, 조병철, 표경호, 홍민희 | Article |
| 2018 | Effects of Serum Albumin, Calcium Levels, Cancer Stage and Performance Status on Weight Loss in Parathyroid Hormone-Related Peptide Positive or Negative Patients with Cancer
| 강은석, 김혜련, 이병완, 이용호, 이지연, 차봉수, 홍남기 | Article |
| 2018 | A Clinical Trial of Combination Neoadjuvant Chemotherapy and Transoral Robotic Surgery in Patients with T3 and T4 Laryngo-Hypopharyngeal Cancer | 금기창, 김다희, 김세헌, 김혜련, 조남훈, 조병철 | Article |
| 2018 | The Benefit of Pro Re Nata Antiemetics Provided With Guideline-Consistent Antiemetics in Delayed Nausea Control | 김건민, 김혜련, 라선영, 손주혁 | Article |
| 2018 | Enhancer Remodeling and MicroRNA Alterations Are Associated with Acquired Resistance to ALK Inhibitors. | 김혜련, 심효섭, 조병철, 표경호, 홍민희 | Article |
| 2017 | Prevalence and prognostic implications of psychological distress in patients with gastric cancer
| 김건민, 김경란, 김혜련, 노성훈, 라선영, 송수경, 정현철 | Article |
| 2017 | Establishment of a Conditional Transgenic Mouse Model Recapitulating EML4-ALK-Positive Human Non-Small Cell Lung Cancer | 강한나, 김상균, 김성무, 김혜련, 김환, 윤미란, 임선민, 조병철, 표경호 | Article |
| 2017 | Detection of activating and acquired resistant mutation in plasma from EGFR-mutated NSCLC patients by peptide nucleic acid (PNA) clamping-assisted fluorescence melting curve analysis
| 김지형, 김혜련, 박형순, 심효섭, 이진구, 이창영, 조병철, 차윤진, 허수진, 홍민희 | Article |
| 2017 | Optimal dose and volume for postoperative radiotherapy in brain oligometastases from lung cancer: a retrospective study
| 김혜련, 서창옥, 이창걸, 장종희, 조병철 | Article |
| 2017 | Co-clinical trials demonstrate predictive biomarkers for dovitinib, an FGFR inhibitor, in lung squamous cell carcinoma | 김은영, 김진아, 김혜련, 백순명, 심효섭, 이진구, 조병철, 홍민희 | Article |
| 2017 | Predictive factors of early distant brain failure after gamma knife radiosurgery alone in patients with brain metastases of non-small-cell lung cancer | 김혜련, 박용구, 장원석, 장진우, 정현호, 조병철 | Article |
| 2017 | Clinical trial of nintedanib in patients with recurrent or metastatic salivary gland cancer of the head and neck: A multicenter phase 2 study (Korean Cancer Study Group HN14-01) | 김혜련, 조재용 | Article |
| 2017 | Osimertinib or Platinum-Pemetrexed in EGFR T790M-Positive Lung Cancer
| 김혜련 | Article |
| 2017 | A randomized; phase II study of gefitinib alone versus nimotuzumab plus gefitinib after platinum-based chemotherapy in advanced non-small cell lung cancer (KCSG LU12-01) (vol 8; pg 15943; 2017)
| 김주항, 김혜련, 정인경, 조병철 | Article |
| 2017 | Next-generation sequencing reveals novel resistance mechanisms and molecular heterogeneity in EGFR-mutant non-small cell lung cancer with acquired resistance to EGFR-TKIs | 김상우, 김성무, 김혜련, 양인석, 이충근, 조병철 | Article |
| 2017 | Transoral robotic surgery-based therapy in patients with stage III-IV oropharyngeal squamous cell carcinoma | 금기창, 김세헌, 김혜련, 박영민, 조남훈, 조병철 | Article |
| 2017 | Concordance of programmed death-ligand 1 expression between primary and metastatic non-small cell lung cancer by immunohistochemistry and RNA in situ hybridization
| 김혜련, 심효섭, 이진구, 이창영, 정인경, 조병철, 차윤진, 홍민희 | Article |
| 2017 | Open-Label, Multicenter, Phase II Study of Ceritinib in Patients With Non-Small-Cell Lung Cancer Harboring ROS1 Rearrangement. | 김주항, 김혜련, 심효섭, 임선민, 조병철 | Article |
| 2017 | Significance of immune checkpoint proteins in EGFR-mutant non-small cell lung cancer | 김혜련, 조병철 | Article |
| 2017 | Validation of ALK/ROS1 Dual Break Apart FISH Probe probe in non-small-cell lung cancer | 김혜련, 심효섭, 조병철, 차윤진 | Article |
| 2017 | Architectural patterns of p16 immunohistochemical expression associated with cancer immunity and prognosis of head and neck squamous cell carcinoma | 김은경, 김혜련, 윤선옥, 조병철, 허수진 | Article |
| 2017 | Activity and safety of AZD3759 in EGFR-mutant non-small-cell lung cancer with CNS metastases (BLOOM): a phase 1, open-label, dose-escalation and dose-expansion study | 김혜련, 조병철 | Article |
| 2016 | Genomic profiling of lung adenocarcinoma patients reveals therapeutic targets and confers clinical benefit when standard molecular testing is negative
| 김은영, 김혜련, 백순명, 심효섭, 임선민, 임승택, 조병철 | Article |
| 2016 | Pilot Study of a Next-Generation Sequencing-Based Targeted Anticancer Therapy in Refractory Solid Tumors at a Korean Institution
| 김상우, 김혜련, 박형순, 이민구 | Article |
| 2016 | Induction docetaxel and S-1 followed by concomitant radiotherapy with low-dose daily cisplatin in locally advanced head and neck carcinoma | 고윤우, 김주항, 김혜련, 이창걸, 조병철, 최은창 | Article |
| 2016 | Longitudinal monitoring of EGFR mutations in plasma predicts outcomes of NSCLC patients treated with EGFR TKIs: Korean Lung Cancer Consortium (KLCC-12-02)
| 김혜련 | Article |
| 2016 | Clinicopathological and prognostic significance of programmed cell death ligand-1 expression in lung adenocarcinoma and its relationship with p53 status. | 김혜련, 심효섭, 이창영, 조병철, 차윤진 | Article |
| 2016 | EGFR-Mediated Reactivation of MAPK Signaling Induces Acquired Resistance to GSK2118436 in BRAF V600E-Mutant NSCLC Cell Lines
| 김민환, 김주항, 김혜련, 문용화, 백순명, 임선민, 조병철 | Article |
| 2016 | Clinical course of stage IV invasive mucinous adenocarcinoma of the lung | 김혜련, 심효섭, 이혜정, 조병철 | Article |
| 2016 | Clinical outcomes in ALK-rearranged lung adenocarcinomas according to ALK fusion variants
| 김혜련, 심효섭, 차윤진 | Article |
| 2016 | Alteration status and prognostic value of MET in head and neck squamous cell carcinoma
| 김혜련, 윤선옥, 조병철, 조윤아, 허수진 | Article |
| 2016 | Next-generation sequencing reveals somatic mutations that confer exceptional response to everolimus
| 김상우, 김소라, 김현기, 김혜련, 김효송, 박형순, 양인석, 이민구, 임선민, 정현철, 조병철 | Article |
| 2016 | A randomized phase II trial of ERCC1 and RRM1 mRNA expression-based chemotherapy versus docetaxel/carboplatin in advanced non-small cell lung cancer | 김혜련, 심효섭, 임선민, 정인경, 조병철, 허수진 | Article |
| 2016 | ER2, a novel human anti-EGFR monoclonal antibody inhibit tumor activity in non-small cell lung cancer models | 김혜련, 박혜지, 임선민, 조병철, 표경호, 한주연 | Article |
http://orcid.org/0000-0002-1842-9070
(Yonsei Health Research Network)
(8583782700)
